Indegene Limited (NSE: INDGN.NS) Stock Competitors & Peer Comparison
See INDGN.NS's competitors and their performance on the NSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for INDGN.NS and its NSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDGN.NS | ₹553.45 | +2.43% | 132.6B | 33.05 | ₹16.65 | +0.41% |
| IKS.NS | ₹1,755.10 | -6.53% | 295.8B | 39.15 | ₹45.03 | N/A |
| IKS.BO | ₹1,753.35 | -6.63% | 295.8B | 41.60 | ₹42.40 | N/A |
| SAGILITY.NS | ₹43.32 | -1.25% | 204.9B | 19.11 | ₹2.29 | +0.11% |
| SAGILITY.BO | ₹43.31 | -1.30% | 204.5B | 20.37 | ₹2.15 | +0.11% |
| INDGN.BO | ₹548.65 | +1.52% | 133.1B | 33.16 | ₹16.65 | +0.41% |
| MEDIASSIST.NS | ₹365.90 | +0.98% | 27.4B | 25.91 | ₹14.17 | N/A |
Stock Comparison
Inventurus Knowledge Solutions Ltd. (NSE: IKS.NS)
INDGN.NS vs IKS.NS Comparison August 2026
Indegene Limited (NSE: INDGN.NS) plays a significant role within the Healthcare sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDGN.NS stands at 132.6B. In comparison, IKS.NS has a market cap of 295.8B. Regarding current trading prices, INDGN.NS is priced at ₹553.45 on the NSE, while IKS.NS trades at ₹1,755.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDGN.NS currently has a P/E ratio of 33.05, whereas IKS.NS's P/E ratio is 39.15. In terms of profitability, INDGN.NS's ROE is +0.14%, compared to IKS.NS's ROE of +0.32%. Regarding short-term risk, INDGN.NS is less volatile compared to IKS.NS. This indicates lower risk in terms of short-term price fluctuations for INDGN.NS.Check IKS.NS's competition here